Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors

被引：0
|
作者：
Sonke, Eric
Angeles, Arkhjamil
Nguyen, Thao Phuong
Bahl, Gaurav
Poon, Vincent Isaac
Bernstein, Vanessa
Weppler, Alison Margaret
Savage, Kerry J.
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] BC Canc, Abbotsford, BC, Canada
[3] BC Canc Agcy Vancouver Isl Ctr, Victoria, BC, Canada
[4] BCCA, Vancouver Ctr, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors
    Wakuda, Kazushige
    Yabe, Michitoshi
    Kodama, Hiroaki
    Nishioka, Naoya
    Miyawaki, Taichi
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Shimizu, Tetsuo
    Gon, Yasuhiro
    Takahashi, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1736 - 1743
  • [42] Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in Singapore
    Lim, Agnes Yeok-Loo
    Chan, Jason Yongsheng
    Oh, Choon Chiat
    DIAGNOSTICS, 2024, 14 (15)
  • [43] TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study
    Virazels, Mathieu
    Lusque, Amelie
    Brayer, Stephanie
    Genais, Matthieu
    Dufau, Carine
    Milhes, Jean
    Filleron, Thomas
    Pages, Cecile
    Sibaud, Vincent
    Mortier, Laurent
    Dereure, Olivier
    Ayyoub, Maha
    Fabre, Amandine
    Andrieu-Abadie, Nathalie
    Pancaldi, Vera
    Colacios, Celine
    Meyer, Nicolas
    Segui, Bruno
    Montfort, Anne
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [44] Long-term survivors among patients with metastatic melanoma treated with targeted agents and/or checkpoint inhibitors
    Linardou, H.
    Laskarakis, A.
    Molfeta, A.
    Sakellariou, K.
    Tarampikou, A.
    Soroli, E.
    Gkiati, K.
    Bafaloukos, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors
    Mantia, Charlene M. M.
    Werner, Lillian
    Stwalley, Brian
    Ritchings, Corey
    Tarhini, Ahmad A. A.
    Atkins, Michael B. B.
    McDermott, David F. F.
    Regan, Meredith M. M.
    MELANOMA RESEARCH, 2022, 32 (01) : 35 - 44
  • [46] Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
    Elkrief, Arielle
    El Raichani, Layal
    Richard, Corentin
    Messaoudene, Meriem
    Belkaid, Wiam
    Malo, Julie
    Belanger, Karl
    Miller, Wilson
    Jamal, Rahima
    Letarte, Nathalie
    Wong, Philip
    Routy, Bertrand
    ONCOIMMUNOLOGY, 2019, 8 (04):
  • [47] Impact of early steroids use on clinical outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors
    Fuca, G.
    Poggi, M.
    Galli, G.
    Imbimbo, M.
    Lo Russo, G.
    Signorelli, D.
    Vitali, M.
    Ganzinelli, M.
    Zilembo, N.
    de Braud, F.
    Garassino, M. C.
    Proto, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] A retrospective study on the long-term survival and incidence of metachronous malignancies in advanced melanoma patients treated with immune checkpoint blockade (ICB)
    Verschaeve, F.
    Vandelaer, N.
    Vander Mijnsbrugge, A-S.
    Tijtgat, J.
    Schwarze, J. K.
    Awada, G.
    Kessels, J.
    Aspeslagh, S.
    Cools, W.
    Rogiers, A.
    Neyns, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S933 - S933
  • [49] Evaluation of the clinical benefits of immune checkpoint inhibitors in patients with advanced melanoma.
    Ou, Qiyun
    Yu, Yunfang
    Lin, Dagui
    Fu, Tuping
    Gao, Quanlong
    Luo, Baoming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [50] Efficacy of lipophilic statins on outcomes of patients treated with immune checkpoint inhibitors
    Chiang, Cho-Han
    Chen, Yuan-Jen
    See, Xin Ya
    Chang, Yu-Cheng
    Wang, Shih-Syuan
    Peng, Chun-Yu
    Horng, Chuan-Sheng
    Hsia, Yuan Ping
    Chiang, Cho-Hung
    Peng, Cheng-Ming
    Chiang, Cho-Hsien
    ONCOLOGY, 2023, 101 (09) : 537 - 541
12345